Natco Pharma Limited’s Board of Directors has declared the 3rd interim dividend for the financial year 2025-26. Shareholders will receive Rs.1.50 (75%) per equity share of face value Rs.2/-. The critical record date for determining eligible shareholders is set for Wednesday, February 18, 2026. Payment of this dividend is scheduled to commence shortly thereafter, starting February 26, 2026.
Interim Dividend Declaration for FY 2025-26
The Board of Directors of Natco Pharma Limited, following its meeting today, February 12, 2026, has approved the declaration of the 3rd interim dividend for the ongoing financial year 2025-26. This decision formalizes a substantial payout to its equity shareholders.
Dividend Rate and Face Value
The declared dividend stands at Rs.1.50/- (Rupees One and paise fifty only) per equity share. This represents 75% of the share’s face value, which is Rs.2/- (Rupees two only). This rate applies equally to every equity share held by eligible investors.
Key Dates Established
To ensure accurate distribution, the company has fixed two essential dates:
- Record Date: The eligibility for receiving this interim dividend will be determined based on the records as of Wednesday, the 18th day of February 2026.
- Payment Commencement: The process for the payment of this declared interim dividend will formally begin on February 26, 2026.
The communication was signed by Ch. Venkat Ramesh, Company Secretary & Compliance Officer, confirming the procedural steps for the upcoming payout.
Source: BSE
